Literature DB >> 26573837

Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.

Patricia S Grace1, Joel D Ernst2.   

Abstract

Mycobacterium tuberculosis commonly causes persistent or chronic infection, despite the development of Ag-specific CD4 T cell responses. We hypothesized that M. tuberculosis evades elimination by CD4 T cell responses by manipulating MHC class II Ag presentation and CD4 T cell activation and tested this hypothesis by comparing activation of Ag85B-specific CD4 T cell responses to M. tuberculosis and M. bovis bacillus Calmette-Guérin (BCG) Pasteur in vivo and in vitro. We found that, although M. tuberculosis persists in lungs of immunocompetent mice, M. bovis BCG is cleared, and clearance is T cell dependent. We further discovered that M. tuberculosis-infected macrophages and dendritic cells activate Ag85B-specific CD4 T cells less efficiently and less effectively than do BCG-infected cells, in vivo and in vitro, despite higher production and secretion of Ag85B by M. tuberculosis. During BCG infection, activation of Ag85B-specific CD4 T cells requires fewer infected dendritic cells and fewer Ag-producing bacteria than during M. tuberculosis infection. When dendritic cells containing equivalent numbers of M. tuberculosis or BCG were transferred to mice, BCG-infected cells activated proliferation of more Ag85B-specific CD4 T cells than did M. tuberculosis-infected cells. Differences in Ag85B-specific CD4 T cell activation were attributable to differential Ag presentation rather than differential expression of costimulatory or inhibitory molecules. These data indicate that suboptimal Ag presentation contributes to persistent infection and that limiting Ag presentation is a virulence property of M. tuberculosis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26573837      PMCID: PMC4684992          DOI: 10.4049/jimmunol.1501494

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  HIV-1 Nef impairs MHC class II antigen presentation and surface expression.

Authors:  P Stumptner-Cuvelette; S Morchoisne; M Dugast; S Le Gall; G Raposo; O Schwartz; P Benaroch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.

Authors:  Andrea J Wolf; Beth Linas; Giraldina J Trevejo-Nuñez; Eleanor Kincaid; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages.

Authors:  P Pancholi; A Mirza; N Bhardwaj; R M Steinman
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

4.  Pulmonary immune responses during primary mycobacterium bovis- Calmette-Guerin bacillus infection in C57Bl/6 mice.

Authors:  S A Fulton; T D Martin; R W Redline; W Henry Boom
Journal:  Am J Respir Cell Mol Biol       Date:  2000-03       Impact factor: 6.914

5.  Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.

Authors:  C H Ladel; S Daugelat; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

6.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Cutting edge: a new approach to modeling early lung immunity in murine tuberculosis.

Authors:  Kamlesh Bhatt; Somia Perdow Hickman; Padmini Salgame
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

8.  Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation.

Authors:  David L Hava; Nicole van der Wel; Nadia Cohen; Christopher C Dascher; Diane Houben; Luis León; Sandeep Agarwal; Masahiko Sugita; Maaike van Zon; Sally C Kent; Homayoun Shams; Peter J Peters; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

9.  Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface.

Authors:  Khalid Sendide; Ala-Eddine Deghmane; Jean-Marc Reyrat; Amina Talal; Zakaria Hmama
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein.

Authors:  Scott A Fulton; Scott M Reba; Rish K Pai; Meghan Pennini; Martha Torres; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  25 in total

Review 1.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

2.  Limited Antimycobacterial Efficacy of Epitope Peptide Administration Despite Enhanced Antigen-Specific CD4 T-Cell Activation.

Authors:  Joel D Ernst; Amber Cornelius; Ludovic Desvignes; Jacqueline Tavs; Brian A Norris
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

3.  Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation.

Authors:  Jaffre J Athman; Obondo J Sande; Sarah G Groft; Scott M Reba; Nancy Nagy; Pamela A Wearsch; Edward T Richardson; Roxana Rojas; W Henry Boom; Supriya Shukla; Clifford V Harding
Journal:  J Immunol       Date:  2017-01-25       Impact factor: 5.422

4.  Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation.

Authors:  Cynthia Portal-Celhay; JoAnn M Tufariello; Smita Srivastava; Aleena Zahra; Thais Klevorn; Patricia S Grace; Alka Mehra; Heidi S Park; Joel D Ernst; William R Jacobs; Jennifer A Philips
Journal:  Nat Microbiol       Date:  2016-12-05       Impact factor: 17.745

5.  Bacterial Strain-Dependent Dissociation of Cell Recruitment and Cell-to-Cell Spread in Early M. tuberculosis Infection.

Authors:  B Shoshana Zha; Ludovic Desvignes; Tawania J Fergus; Amber Cornelius; Tan-Yun Cheng; D Branch Moody; Joel D Ernst
Journal:  mBio       Date:  2022-06-13       Impact factor: 7.786

Review 6.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 7.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

8.  Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis.

Authors:  Stephen M Carpenter; Jason D Yang; Jinhee Lee; Palmira Barreira-Silva; Samuel M Behar
Journal:  PLoS Pathog       Date:  2017-11-27       Impact factor: 6.823

9.  A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during Tuberculosis.

Authors:  Stephen M Carpenter; Cláudio Nunes-Alves; Matthew G Booty; Sing Sing Way; Samuel M Behar
Journal:  PLoS Pathog       Date:  2016-01-08       Impact factor: 6.823

10.  Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection.

Authors:  Jonathan Kevin Sia; Erica Bizzell; Ranjna Madan-Lala; Jyothi Rengarajan
Journal:  PLoS Pathog       Date:  2017-08-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.